Search research articles
Contact Us
Filters
Showing results (1-10 of 164) with videos related to
Page
of 17
Sort By:
Pediatric Infectious Disease
|
November 1, 1986
Ureaplasmas of human: with emphasis upon maternal and neonatal infections. Future considerations: maternal and neonatal aspects
G H Cassell
Reviews of Infectious Diseases
|
May 1, 1982
Derrick Edward Award Lecture. The pathogenic potential of mycoplasmas: Mycoplasma pulmonis as a model
G H Cassell
FEMS Immunology and Medical Microbiology
|
August 1, 1997
Emergent antibiotic resistance: health risks and economic impact
G H Cassell
The Western Journal of Medicine
|
February 1, 1995
Severe Mycoplasma disease--rare or underdiagnosed?
G H Cassell
Emerging Infectious Diseases
|
August 26, 1998
Infectious causes of chronic inflammatory diseases and cancer
G H Cassell
Science (New York, N.Y.)
|
March 13, 1987
Transposition of gram-positive transposon Tn916 in Acholeplasma laidlawii and Mycoplasma pulmonis
K Dybvig, G H Cassell
JAMA
|
February 15, 2001
Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance
G H Cassell, J Mekalanos
FEMS Immunology and Medical Microbiology
|
August 1, 1997
The role of scientific societies in addressing the threats of emerging infections: summary of roundtable discussion
G H Cassell, T Shimao
International Journal of Systematic Bacteriology
|
July 1, 1996
Phylogenetic analysis of genes coding for 16S rRNA in mammalian ureaplasmas
R Harasawa, G H Cassell
The New England Journal of Medicine
|
January 8, 1981
Mycoplasmas as agents of human disease
G H Cassell, B C Cole
Page
of 17
Search research articles
Search
Showing results (1-10 of 164) with videos related to
Sort By:
Page
of 17
Pediatric Infectious Disease
|
November 1, 1986
Ureaplasmas of human: with emphasis upon maternal and neonatal infections. Future considerations: maternal and neonatal aspects
G H Cassell
Reviews of Infectious Diseases
|
May 1, 1982
Derrick Edward Award Lecture. The pathogenic potential of mycoplasmas: Mycoplasma pulmonis as a model
G H Cassell
FEMS Immunology and Medical Microbiology
|
August 1, 1997
Emergent antibiotic resistance: health risks and economic impact
G H Cassell
The Western Journal of Medicine
|
February 1, 1995
Severe Mycoplasma disease--rare or underdiagnosed?
G H Cassell
Emerging Infectious Diseases
|
August 26, 1998
Infectious causes of chronic inflammatory diseases and cancer
G H Cassell
Science (New York, N.Y.)
|
March 13, 1987
Transposition of gram-positive transposon Tn916 in Acholeplasma laidlawii and Mycoplasma pulmonis
K Dybvig, G H Cassell
JAMA
|
February 15, 2001
Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance
G H Cassell, J Mekalanos
FEMS Immunology and Medical Microbiology
|
August 1, 1997
The role of scientific societies in addressing the threats of emerging infections: summary of roundtable discussion
G H Cassell, T Shimao
International Journal of Systematic Bacteriology
|
July 1, 1996
Phylogenetic analysis of genes coding for 16S rRNA in mammalian ureaplasmas
R Harasawa, G H Cassell
The New England Journal of Medicine
|
January 8, 1981
Mycoplasmas as agents of human disease
G H Cassell, B C Cole
Page
of 17